Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tritanrix HB+Hib + Quinvaxem
- Development stage
- Unknown
- Lead developer
- GSK
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
This is a vaccination regimen studied for interchangeability, involving the sequential administration of two different pentavalent combination vaccines: Tritanrix HB+Hib (manufactured by GSK) and Quinvaxem (manufactured by Berna Biotech Korea/Crucell). Both vaccines are designed to protect against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, and Haemophilus influenzae type b (Hib) infections. The regimen typically consists of a primary dose of Tritanrix HB+Hib followed by subsequent doses of Quinvaxem. Clinical trials have demonstrated that this mixed schedule is non-inferior to a single-vaccine schedule, supporting the flexibility of pentavalent vaccine use in childhood immunization programs.
- Other names
- DTP-HepB-Hib vaccine regimenpentavalent vaccine interchangeability regimen
02
Targets
PRNP (Cellular Prion Protein)HBsAg (Hepatitis B surface antigen)TT (Tetanus toxoid)
Beyond the preview
Go deeper on Tritanrix HB+Hib + Quinvaxem.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tritanrix HB+Hib + Quinvaxem.